Jump to content
RemedySpot.com

Anabolic steroids- where are the bodies.

Rate this topic


Recommended Posts

Posted

-

There's also the point of ethics in sport. Cheating is what you're doing if you

breach the rules - and people scream quite loudly when someone say, breaks a

rule on the field, right?

If anything, people need to be less comfy about AAS and other cheats and perhaps

return their thinking to a more level way of viewing ALL cheating as cheating.

The Phantom

aka Schaefer, CMT/RMT, competing powerlifter

Denver, Colorado USA

Anabolic steroids- where are the bodies.

Ralph Giarnella MD wrote:

You apparently missed the point of the article. There are numerous case

studies of young weight lifters and body builders who abused AAS and died

and subsequently underwent autopsy. These are individuals who had no other

risk factors for heart disease. When a person dies of heart disease because

of a bad diet the death certificate does not state that they died because

they had a poor diet. It just states they died of a heart attack. Death

certificates do not state that an individual died because of obesity nor

does it state that they died as the result of smoking. Death certificates

list the conditions caused by these conditions such as heart diseasea,

diabetes, emphysema or copd. As a matter of fact in my state (Connecticut)

only recently has there been a box to check off is smoking might have been a

contributing cause of this persons death. There is no box to check for

alcohol abuse, obesity or eating at Mcs. a

There is plenty of science available in the literature concerning the

dangers of AAS, however the AAS apologists conveninetly ignore the science.

Casler writes:

I think it is extremely important to take an informed viewpoint that looks

at all the implications. Anabolic Steroids and other endocrine drugs can be

abused or they can be used. This means don't be an apologist nor an

alarmist regarding the subject.

We also need to disassociate their medical use with the abuse and cheating

usage in sports.

While you can draw associations with cases that may have been caused by

abuse, we should not let that hamper the proper medical use of such

medications to improve health and the quality of life. There is MUCH

evidence that the proper medical use will NOT cause heart and coronary

disease, but it will reduce or prevent it. The hysteria that surrounds

hormonal abuse is likely warranted, but it need be tempered and disconnected

from their positive medical implementation.

Insulin is another hormone more commonly used in a medical sense and is

arguably more anabolic than testosterone. It is also even more dangerous if

abused or used improperly, so I think we need adapt the same viewpoint to

all exogenous hormonal use. Broad brush hand waving creates a strange

phenomenon whereby the " good " that can be done thwarts the amount of

research that needs to be carried out to be truly helpful.

HRT (hormone replacement therapy) is beginning to gain an interest and it

would seem that if the " balancing act " of using the medications properly is

more sophisticated that it will in fact REDUCE cancers, heart disease, sarco

and osteopenia, diabetes, metabolic syndrome, and many other ailments that

manifest (especially) males as they suffer a reduction in testosterone

production.

Enlarged hearts and other heart conditions assigned to steroid abuse may

certainly be true, but years before steroid abuse was around these same

conditions fell many former athletes.

I'm just suggesting not to throw the baby out with the bath water. I think

in the future, if we can get beyond this publicity generated hysteria, so

that endocrine science will advance and health and the quality of life will

be enhanced and improved with greater understanding and implementation.

Just like we now know more about nutrition, and how manipulating our intakes

can be positive, we will likely see that we can also learn how to control

hormonal/endocrine levels to a better and healthier result.

Regards,

Casler

TRI-VECTOR 3-D Training Systems

Century City, CA

-II-----II-

Posted

Kenny,

I don't think that an HBO story of steroid use covering what a few people call

the lack of evidence supporting the dangers of using or abusing steroids a

viable counter to the sample of evidence Dr. Ralph is providing, which is the

tip of the iceberg when it comes to research regarding the use and abuse of AAS.

Casey Gallagher CSCS

Snohomish, WA USA

>

>

> Ralph,

>

> You apparently can come up with defenitive data.

>

> Drug abuse of any medication cause health issues or leads you down the road to

a quick demise.

>

> Drinking too my water will kill you, hyponatramia.

>

> There is plenty of data form medical experts and the federal government that

counter your statements. Here a quick look at some of it.

http://www.youtube.com/watch?v=z0LEj8IPHGU & feature=related

>

> I will be more than happy to provide with a plethra of data that refutes what

you've presented.

>

> With that said, I am a proponent of just tell the truth and let the chips

fall...

>

> Kenny Croxdale

> Rio Rancho, NM

>

>

>

>

>

> Re: Anabolic steroids- where are the bodies.

>

> A common refrain amongst apologists for anabolic steroids is : Where are the

> bodies? The bodies are in the cemetary ony the death certificated does not

> state they died from steroids. The most likely cause of death heart disease.

> It might be cardiac arrhythmia or acute MI.

>

> There is an excellent article in the American Journal of Cardiology which

> reviews A total of 49 studies describing 1,467 athletes were reviewed to

> investigate the cardiovascular effects of the abuse of AAS.

> It cites 99 articles covering this topic. If you are interested in this topic

> go to your local hospital Library and check out :

>

> Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

> Blood Pressure, Left Ventricular Dimensions, and

>

> Rhythm

> The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

> Copyright © 2010 The American College of Cardiology -

>

> Because of copyright and space I cannot put the article here but I have taken

> the time to excerpt some of the information I thought might be pertinent along

> with the articles or journals cited.

>

> You are not likely to find these studies in your typical muscle magazine or

> website. Some of these studies date back to the mid 80s and 90s. The

> information is not new just conveniently ignored.

>

> ***********************

>

> Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

> Blood Pressure, Left Ventricular Dimensions, and Rhythm

>

> The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

> Copyright © 2010 The American College of Cardiology -

>

> AAS and abnormal plasma lipoproteins

>

> AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

> studies suggest that AAS abuse in athletes increase low-density lipoprotein

> (LDL)

>

> levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

> (HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

> [43] , [44]

>

> By some estimates, these lipoprotein abnormalities increase

> the risk for coronary artery disease by three- to sixfold. [14] , [45]

>

> 13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

> D.S.: Androgenic anabolic steroids and arterial structure and function in male

>

> bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

>

> 14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't

Laar

> A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

> blood

>

> pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

> 19-23.1988; Abstrac

> 36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

> serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

> 970-

>

> 972.1996; Abstract

> 37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

> Cardiol 17. 281-288.1987; Abstract

>

> 38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

> Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

> subjects. J Clin

>

> Pharmacol 36. 1132-1140.1996; Abstract

> 39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

> Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

> during and after self-

>

> administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

> 40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

> profile of body builders with and without self-administration of anabolic

> steroids. Eur J

>

> Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

> 41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

> Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein

(a).

> Br J Sport

>

> Med 38. 253-259.2004;

>

> 42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F.,

Davies

> J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

> steroids. Eur J

>

> Clin Invest 36. 483-488.2006; Abstract

> 43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

> steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

> Abstract

>

> 44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

> M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

>

> echocardiographic parameteres in body builders. Int J Sports Med 10.

> 62-66.1989; Abstract

>

> 45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

> A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

>

> AAS, acute MI, and sudden death

> Alarming data have linked AAS with fatal events, although these are mostly

> case-control studies and case reports of acute coronary syndromes, MIs, and

> ventricular

>

> arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

>

> 88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

> Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic

and

>

> toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

> 48-53.2007; Abstract

>

> 89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

> toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

>

> 90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

> connection?. Med Hypotheses 35. 27-31.1991; Abstract

>

> 91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

> 21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

> 411-412.1996; Citation

>

> 92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

> steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

> 507-

>

> 508.1992; Citation

> 93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

> user. Med Sci Sport Exer 26. 408-413.1994;

>

> 94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

> extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

> 50. 222-

>

> 223.1996; Abstract

>

> a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years)

suggested

>

> primary cardiac pathology in 1/3, [23]

>

> 23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

> anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

>

> recent case-control study [24] , [25] suggested cardiac causes in 2/3 of

deaths,

>

> with others being attributed to suicide, hepatic coma, and malignancy.

>

> 24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

> premature mortality of competitive powerlifters suspected to have used

anabolic

> agents. Int J Sports Med 21. 225-227.2000; Abstrac

>

> 25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

> athletes. Sports Med 2002. 83-84.2002; 2

>

> Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

> experienced sudden cardiac arrest. Postmortem examination revealed ventricular

> hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

> attributed to arrhythmic sudden death secondary to AAS abuse.

> 84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping

agents)

> and sudden death†" a case report and review of the literature. Int J Legal Med

> 111. 261-264.1998; Abstrac

>

> McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who

admitted

> to AAS abuse but lacked cardiac risk factors. The patient presented with

> markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no

family

>

> history of premature atherosclerosis or cardiac events. Within a month of

> discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

> mg/dl.

>

> 46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

> infarction in a 22-year-old world class weight lifter using anabolic steroids.

> Am J Cardiol62.164.1988; Citation

>

> 49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

>

> Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

> who abused nandrolone and presented with an acute MI without traditional

cardiac

>

> risk factors. Acute angiography revealed extensive left anterior descending

> coronary artery thrombosis, which was managed by thrombolysis. Angiography in

> the subacute phase confirmed very mild luminal irregularity at the site of

> previous thrombosis.

>

> 69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

> steroids. Ulster Med J 62. 174-176.1993; Citation

>

> The most commonly observed arrhythmias, typically occurring during physical

> exertion, include atrial fibrillation, ventricular fibrillation, ventricular

> tachycardia, and supraventricular and ventricular ectopic beats. [95]

> 95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

> cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14.

487-494.2007;

>

> Abstract

>

> Dickerman et al [96] reported a 20-year-old male bodybuilder who

> self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

> indicated LVH with a cardiac mass >2 times the upper limit of normal.

>

> 96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac

death

>

> in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

> 172-173.1995; Abstract

>

> ******************

> Ralph Giarnella MD

> Southington Ct. USA

>

>

Posted

The Phantom wrote

-

There's also the point of ethics in sport. Cheating is what you're doing if

you breach the rules - and people scream quite loudly when someone say,

breaks a rule on the field, right?

If anything, people need to be less comfy about AAS and other cheats and

perhaps return their thinking to a more level way of viewing ALL cheating as

cheating.

Casler writes:

Hi ,

I agree and haven't suggested supporting cheating in athletic competition in

any way, nor have I suggested that the " abuse " of steroids is positive in

any way. My point is to be careful in the message sent regarding all uses

of exogenous hormones, so that they do not get a broad brush demonization.

The facts of the matter are that one of the key elements to aging, and the

diseases of aging is the reduced and changing hormonal production and

profile. This is an area that needs some serious research, especially in

this age of Baby Boomers increasing in numbers. We have a healthcare

problem of incredible proportion and hormonal profiling appears to offer

some serious benefits. You would be hard pressed to find any major disease

that is not related to hormone deficiency, or profile.

And this too needs to be approached seriously and not too enthusiastically

as a " fountain of youth " without the proper research.

I find it a great challenge to age with various nutritional and training

strategies to maintain health and performance. I think in the future we

will have a better grasp on various methods of maintaining a more youthful

and healthy endocrine profile. The results will hopefully be a reduction in

age related diseases. It is important that the general public is not led

into an association of any employment of these means as cheating or

dangerous when undertaken in a valid medical usage.

My point is to make sure and define USE versus ABUSE.

As well, there is also some discussion linking Steroid " abuse " /use to

suicide. I find that a difficult case to make on its own. I think you

could create a similar case to just being a teenager since they tend to

commit suicide at an ALARMING rate. The real truth is likely somewhere in

between. The answer is likely that the " emotional type " of person who feels

the need to abuse drugs and or steroids is more likely to commit suicide.

Most of them probably also drink coffee, and have other common practices,

and environmental similarities but the correlation is not drawn.

Rant over. . . .

Regards,

Casler

TRI-VECTOR 3-D Training Systems

Century City, CA

-II-----II-

Posted

Tom,

I am a bit puzzled as to what " gathering longevity data on athletes who threw

the discus, shot, and hammer between 1960 and 1985 " has to do with this topic.

Kenny Croxdale

Rio Rancho, NM

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

Kenny,

I read your post and in it you stated, " There is plenty of data form [sic]

medical experts and the federal government that counter your statements.

(Here's) a quick look at some of it. "

You then used a news show, which as Dr. Ralph posted, lacks credibility and

validity in it's claims, to support your point.

If you have a plethera of evidence to support your claim that there is " plenty

of data " to refute Dr. Ralph's point, please, by all means share it.

Casey Gallagher CSCS

Snohomish, WA USA

>

> Casey,

>

> I stated that the Real Sports report with Armen Keteyian (currently with CBS

News) was " a quick look at it " ...that meanint it provided some information on

the subject.

>

> I have some additional in depth documentation on the matter.

>

> As I previously stated, abuse of AAS or for that matter any other medication

will eventually cause problems. Please re-read my post.

>

> Kenny Croxdale, CSCS

> Rio Rancho, NM

>

>

>

>

>

> Re: Anabolic steroids- where are the bodies.

>

>

>

>

> Kenny,

>

> I don't think that an HBO story of steroid use covering what a few people call

the lack of evidence supporting the dangers of using or abusing steroids a

viable counter to the sample of evidence Dr. Ralph is providing, which is the

tip of the iceberg when it comes to research regarding the use and abuse of AAS.

>

> =====================

>

Posted

Kenny,

You're not serious? Steroid use among these athletes during that period was

extremely high. While we can't broach this question directly, the data might

provide some relevant information on the topic.

Tom Fahey

California State University, Chico

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

Copyright © 2010 The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA

Posted

All,

Having experienced the AAS world directly as it existed in powerlifting, and

tangentially as it was in the track and field throwing events, from the late

60’s up until the mid-80’s, I would like to ask this discussion to not overlook

the point made by Dr. Giarnella: supra-physiological.

In my experience, those who used AAS initially, likely a strong majority,

generally kept to doses within or at least close to FDA guidelines, interspersed

with phases of abstinence. Over time, I noticed this practice was gradually

being displaced by reckless dose-escalation, stacking of agents, both oral and

injectable, and a reluctance to “get clean”, even for a brief period of time.

So while the incidence of drug use during that period (1960-1985) was indeed

likely very high as noted, it was not initially typified by the prevalent

insanity that came later, circa late 70’s and onward: the latter being one of

the major reason I elected to stop use personally, along with the unknowns

regarding use over many years.

Just my $0.02...

Regards and Happy holidays!

Dr. Jim Klostergaard

Houston, TX

On 12/23/10 10:56 AM, " Tom Fahey " <discusdoc@...> wrote:

Kenny,

You're not serious? Steroid use among these athletes during that period was

extremely high. While we can't broach this question directly, the data might

provide some relevant information on the topic.

Tom Fahey

California State University, Chico

Re: Anabolic steroids- where are the bodies.

A common refrain amongst apologists for anabolic steroids is : Where are the

bodies? The bodies are in the cemetary ony the death certificated does not

state they died from steroids. The most likely cause of death heart disease.

It might be cardiac arrhythmia or acute MI.

There is an excellent article in the American Journal of Cardiology which

reviews A total of 49 studies describing 1,467 athletes were reviewed to

investigate the cardiovascular effects of the abuse of AAS.

It cites 99 articles covering this topic. If you are interested in this topic

go to your local hospital Library and check out :

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and

Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

The American College of Cardiology -

Because of copyright and space I cannot put the article here but I have taken

the time to excerpt some of the information I thought might be pertinent along

with the articles or journals cited.

You are not likely to find these studies in your typical muscle magazine or

website. Some of these studies date back to the mid 80s and 90s. The

information is not new just conveniently ignored.

***********************

Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids,

Blood Pressure, Left Ventricular Dimensions, and Rhythm

The American Journal of Cardiology - Volume 106, Issue 6 (September 2010) -

The American College of Cardiology -

AAS and abnormal plasma lipoproteins

AAS abuse has been linked with abnormal plasma lipoproteins (Table 1). Several

studies suggest that AAS abuse in athletes increase low-density lipoprotein

(LDL)

levels by >20% [14] , [36] , [37] , [38] and decrease high-density lipoprotein

(HDL) levels by 20% to 70%. [13] , [14] , [37] , [39] , [40] , [41] , [42] ,

[43] , [44]

By some estimates, these lipoprotein abnormalities increase

the risk for coronary artery disease by three- to sixfold. [14] , [45]

13 Sader M.A., Griffiths K.A., McCredie R.J., Handelsman D.J., Celermajer

D.S.: Androgenic anabolic steroids and arterial structure and function in male

bodybuilders. J Am Coll Cardiol 37. 224-230.2001; Abstract

14 Lenders J.W., Demacker P.N., Vos J.A., Jansen P.L., Hoitsma A.J., Van't Laar

A., Thien T.: Deleterious effects of anabolic steroids on serum lipoproteins,

blood

pressure, and liver function in amateur bodybuilders. Int J Sports Med 9.

19-23.1988; Abstrac

36 Lajarin F., Zaragoza R., r I., ez- P.: Evolution of

serum lipids in two male bodybuilders using anabolic steroids. Clin Chem 42.

970-

972.1996; Abstract

37 McKillop G., Ballantyne D.: Lipoprotein analysis in bodybuilders. Int J

Cardiol 17. 281-288.1987; Abstract

38 Palatini P., Giada F., Garavelli G., Sinisi F., L., Michieletto M.,

Baldo-Enzi G.: Cardiovascular effects of anabolic steroids in weight-trained

subjects. J Clin

Pharmacol 36. 1132-1140.1996; Abstract

39 Baldo-Enzi G., Giada F., Zuliani G., Baroni L., Vitale E., Enzi G.,

Magnanini P., Fellin R.: Lipid and apoprotein modifications in body builders

during and after self-

administration of anabolic steroids. Metabolism 39. 203-208.1990; Abstract

40 Fröhlich J., Kullmer T., Urhausen A., Bergmann R., Kindermann W.: Lipid

profile of body builders with and without self-administration of anabolic

steroids. Eur J

Appl Physiol 59. 98-103.1989; 41 Hartgens F., Rietjens G., K

41 Hartgens F., Rietjens G., Keizer H.A., Kuipers H., Wolffenbuttel B.:

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Br J Sport

Med 38. 253-259.2004;

42 Lane H., Grace F., J.C., K., Cockcroft J., Scanlon M.F., Davies

J.S.: Impaired vasoreactivity in bodybuilders using androgenic anabolic

steroids. Eur J

Clin Invest 36. 483-488.2006; Abstract

43 Urhausen A., Albers T., Kindermann W.: Are the cardiac effects of anabolic

steroid abuse in strength athletes reversible?. Heart 90. 496-501.2004;

Abstract

44 Zuliani U., Bernardini B., Catapano A., Campana M., Cerioli G., Spattini

M.: Effects of anabolic steroids, testosterone, and HGH on blood lipids and

echocardiographic parameteres in body builders. Int J Sports Med 10.

62-66.1989; Abstract

45 Glazer G.: Atherogenic effects of anabolic steroids on serum lipid levels.

A literature reviewArch Intern Med 151. 1925-1933.1991; Abstract

AAS, acute MI, and sudden death

Alarming data have linked AAS with fatal events, although these are mostly

case-control studies and case reports of acute coronary syndromes, MIs, and

ventricular

arrhythmias. [24] , [46] , [83] , [84] , [85] , [86] , [87] , [88]

88 Fineschi V., Riezzo I., Centini F., Silingardi E., Licata M., Beduschi G.,

Karch S.B.: Sudden cardiac death during anabolic steroid abuse: morphologic and

toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121.

48-53.2007; Abstract

89 Sullivan M.L., ez C.M., Gennis P., Gallagher E.J.: The cardiac

toxicity of anabolic steroids. Prog Cardiovasc Dis 41. 1-15.1998; Abstract

90 Ferenchick G.: Anabolic/androgenic steroid abuse and thrombosis: is there a

connection?. Med Hypotheses 35. 27-31.1991; Abstract

91 Roeggia M., Heinz G., Werba E., Roeggla G.: Cardiac tamponade in a

21-year-old body builder with anabolica abuse. Br J Clin Pract 50.

411-412.1996; Citation

92 Ferenchick G., Adelman S.: Myocardial infarction associated with anabolic

steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124.

507-

508.1992; Citation

93 Huie M.: An acute myocardial infarction occurring in an anabolic steroid

user. Med Sci Sport Exer 26. 408-413.1994;

94 Fisher M., Appleby M., Rittoo D., Cotter L.: Myocardial infarction with

extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract

50. 222-

223.1996; Abstract

a postmortem study of male Caucasian AAS abusers (aged 20 to 45 years) suggested

primary cardiac pathology in 1/3, [23]

23 Thiblin I., Lindquist O., Rajs J.: Cause and manner of death among users of

anabolic androgenic steroids. J Forensic Sci 45. 16-23.2000; Abstract

recent case-control study [24] , [25] suggested cardiac causes in 2/3 of deaths,

with others being attributed to suicide, hepatic coma, and malignancy.

24 Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T.: Increased

premature mortality of competitive powerlifters suspected to have used anabolic

agents. Int J Sports Med 21. 225-227.2000; Abstrac

25 Parssinen M., Seppala T.: Steroid use and long-term health risks in former

athletes. Sports Med 2002. 83-84.2002; 2

Hausmann et al [84] describe a 23-year-old male bodybuilder who abused AAS and

experienced sudden cardiac arrest. Postmortem examination revealed ventricular

hypertrophy, myocardial fibrosis, and acute MI, and the cause of death was

attributed to arrhythmic sudden death secondary to AAS abuse.

84 Hausmann R., Hammer S., Betz P.: Performance enhancing drugs (doping agents)

and sudden death—a case report and review of the literature. Int J Legal Med

111. 261-264.1998; Abstrac

McNutt et al[46] reported an acute MI in a 22-year-old bodybuilder who admitted

to AAS abuse but lacked cardiac risk factors. The patient presented with

markedly elevated LDL (596 mg/dl) and depressed HDL (14 mg/dl) yet had no family

history of premature atherosclerosis or cardiac events. Within a month of

discontinuing AAS, his LDL decreased to 220 mg/dl and his HDL increased to 35

mg/dl.

46 McNutt R.A., Ferenchick G.S., Kirlin P.C., Hamlin N.J.: Acute myocardial

infarction in a 22-year-old world class weight lifter using anabolic steroids.

Am J Cardiol62.164.1988; Citation

49 Bowman S.: Anabolic steroids and infarction. BMJ 300. 750.1990; Citation

Figure 1 shows the presenting electrocardiogram of a 25-year-old male athlete

who abused nandrolone and presented with an acute MI without traditional cardiac

risk factors. Acute angiography revealed extensive left anterior descending

coronary artery thrombosis, which was managed by thrombolysis. Angiography in

the subacute phase confirmed very mild luminal irregularity at the site of

previous thrombosis.

69 Kennedy C.: Myocardial infarction in association with misuse of anabolic

steroids. Ulster Med J 62. 174-176.1993; Citation

The most commonly observed arrhythmias, typically occurring during physical

exertion, include atrial fibrillation, ventricular fibrillation, ventricular

tachycardia, and supraventricular and ventricular ectopic beats. [95]

95 Furlanello F., Serdoz L.V., Cappato R., De Ambroggi L.: Illicit drugs and

cardiac arrhythmias in athletes. Eur J Cardiovasc Prev Rehabil 14. 487-494.2007;

Abstract

Dickerman et al [96] reported a 20-year-old male bodybuilder who

self-administered AAS 700 mg/week and had sudden cardiac arrest. Autopsy

indicated LVH with a cardiac mass >2 times the upper limit of normal.

96 Dickerman R.D., Schaller F., Prather I., McConathy W.J.: Sudden cardiac death

in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86.

172-173.1995; Abstract

******************

Ralph Giarnella MD

Southington Ct. USA?

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...